» Articles » PMID: 12488620

Genetic Stabilization by P53 Involves Growth Regulatory and Repair Pathways

Overview
Specialty Biology
Date 2002 Dec 19
PMID 12488620
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

p53 performs a plethora of activities, which are directed towards the maintenance of the genomic integrity and constitute its universal role as a tumor suppressor. 1000 to 10000 latent p53 molecules are permanently available in order to monitor DNA exchange processes in mitotically growing cells. After the introduction of major DNA injuries the levels of posttranslationally modified p53 proteins rise, which in turn transcriptionally signal transient cell cycle arrest or apoptotic cell death, depending on the extent of damage. Taken together, p53 inhibits the manifestation of genomic instabilities at different control levels both during naturally occurring metabolic processes and in response to genotoxic treatments.

Citing Articles

Classification of TP53 mutations and HPV predict survival in advanced larynx cancer.

Scheel A, Bellile E, McHugh J, Walline H, Prince M, Urba S Laryngoscope. 2016; 126(9):E292-9.

PMID: 27345657 PMC: 5002993. DOI: 10.1002/lary.25915.


More targets, more pathways and more clues for mutant p53.

Garritano S, Inga A, Gemignani F, Landi S Oncogenesis. 2013; 2:e54.

PMID: 23817466 PMC: 3740285. DOI: 10.1038/oncsis.2013.15.


TP53 status and response to treatment in breast cancers.

Varna M, Bousquet G, Plassa L, Bertheau P, Janin A J Biomed Biotechnol. 2011; 2011:284584.

PMID: 21760703 PMC: 3114547. DOI: 10.1155/2011/284584.


Recombinational DNA Repair in Cancer and Normal Cells: The Challenge of Functional Analysis.

Willers H, Xia F, Powell S J Biomed Biotechnol. 2002; 2(2):86-93.

PMID: 12488588 PMC: 153788. DOI: 10.1155/S1110724302204027.

References
1.
McGill G, Fisher D . p53 and cancer therapy: a double-edged sword. J Clin Invest. 1999; 104(3):223-5. PMC: 408427. DOI: 10.1172/JCI7861. View

2.
Oberosler P, Hloch P, Ramsperger U, Stahl H . p53-catalyzed annealing of complementary single-stranded nucleic acids. EMBO J. 1993; 12(6):2389-96. PMC: 413469. DOI: 10.1002/j.1460-2075.1993.tb05893.x. View

3.
Xia S, Shammas M, Shmookler Reis R . Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase. Mol Cell Biol. 1997; 17(12):7151-8. PMC: 232572. DOI: 10.1128/MCB.17.12.7151. View

4.
Huang P . Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 protein. Oncogene. 1998; 17(3):261-70. DOI: 10.1038/sj.onc.1201946. View

5.
Komarov P, Komarova E, Kondratov R, Coon J, Chernov M, Gudkov A . A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science. 1999; 285(5434):1733-7. DOI: 10.1126/science.285.5434.1733. View